Fatty liver disease linked to higher mortality risk from many common diseases

Targeting hormones could reduce risk of fatty liver disease

A deeper understanding of a gene that predisposes patients to fatty liver disease may open new avenues for treatment of the condition, according to Yale research published in Cellular and Molecular Gastroenterology and Hepatology.

Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment

Μetabolic dysfunction-associated steatotic liver disease (MASLD) comprises a heterogeneous condition in the presence of steatotic liver. There can be a hierarchy of metabolic risk factors contributing to the severity of metabolic dysfunction and, thereby, the associated risk of both liver and extrahepatic outcomes, but the precise ranking and combination of metabolic syndrome (MetS) traits that convey the highest risk of major adverse liver outc…

Fatty liver linked to increased risk of death from several diseases

A comprehensive study shows that people with fatty liver disease have almost twice the mortality rate of the general population. They have an increased risk of dying from both liver diseases and common diseases such as cancer and cardiovascular disease.

Fatty liver disease linked to higher mortality risk from many common diseases

A comprehensive study from Karolinska Institutet shows that people with fatty liver disease have almost twice the mortality rate of the general population.

Gallstones May Be the First Sign of Fatty Liver Disease

Fact checked by Nick BlackmerPhoto Illustration by Michela Buttignol for Verywell Health; Getty ImagesFatty liver disease is often called a “silent epidemic” because it can progress for years without symptoms until severe complications hit.Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as nonalcoholic fatty liver disease, affects about 38% of adults worldwide. As with many conditions, catching it early can mak…

One in three people in Europe has a liver disease and often doesn't know it. An alarming fact that also concerns millions of Italians, threatened by a silent but growing pathology: steatosis associated with metabolic dysfunction (MASLD), often known as fatty liver. The good news is...